These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 1452517

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F, Lühr I, Kunze T, Mundhenke C, Maass N, Erhart T, Denker M, Beckmann D, Tiemann M, Schulte C, Dohrmann P, Cavaillé F, Godeau F, Gespach C.
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [Abstract] [Full Text] [Related]

  • 3. [Intravascular blood coagulation and its role in malignant neoplasms].
    Pavlovskiĭ DP.
    Vopr Onkol; 1981 Jun; 27(7):96-103. PubMed ID: 7023043
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hemostatic abnormalities associated with cancer and its therapy.
    Glassman AB.
    Ann Clin Lab Sci; 1997 Jun; 27(6):391-5. PubMed ID: 9433535
    [Abstract] [Full Text] [Related]

  • 7. The effect of suramin on laboratory tests of coagulation.
    Horne MK, Wilson OJ, Cooper M, Gralnick HR, Myers CE.
    Thromb Haemost; 1992 Apr 02; 67(4):434-9. PubMed ID: 1631791
    [Abstract] [Full Text] [Related]

  • 8. Acquired coagulation factor inhibitors.
    Saraya AK, Pati HP.
    J Assoc Physicians India; 1992 Jan 02; 40(1):11-2. PubMed ID: 1634453
    [No Abstract] [Full Text] [Related]

  • 9. Acquired circulating anticoagulants in malignancy.
    Kunkel LA.
    Semin Thromb Hemost; 1992 Jan 02; 18(4):416-23. PubMed ID: 1470928
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of procoagulant activities in extracts of normal and malignant human tissue.
    Gordon SG, Franks JJ, Lewis BJ.
    J Natl Cancer Inst; 1979 Apr 02; 62(4):773-6. PubMed ID: 285292
    [Abstract] [Full Text] [Related]

  • 11. [Haemostaseological aspects of perioperative blood management].
    Scherer RU.
    Zentralbl Chir; 2003 Jun 02; 128(6):473-80. PubMed ID: 12865952
    [Abstract] [Full Text] [Related]

  • 12. [Hemostatic mechanisms and malignant tumors].
    Kase F, Pospísil J, Hlousková D.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985 Jun 02; 112(6):809-30. PubMed ID: 2419210
    [Abstract] [Full Text] [Related]

  • 13. [Expression evaluation of in loco coagulation system in colorectal cancer].
    Sierko E, Tokajuk P, Butkiewicz A, Sulkowski S, Zimnoch L, Wojtukiewicz MZ.
    Pol Merkur Lekarski; 2005 Feb 02; 18(104):176-9. PubMed ID: 17877125
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The biologic basis for anticoagulant treatment of cancer.
    Zacharski LR.
    Prog Clin Biol Res; 1982 Feb 02; 89():113-29. PubMed ID: 7111295
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Microparticles, thrombosis and cancer.
    Aharon A, Brenner B.
    Best Pract Res Clin Haematol; 2009 Mar 02; 22(1):61-9. PubMed ID: 19285273
    [Abstract] [Full Text] [Related]

  • 18. The role of procoagulants and anticoagulants in the development of venous thromboembolism.
    Bertina RM.
    Thromb Res; 2009 Mar 02; 123 Suppl 4():S41-5. PubMed ID: 19303503
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.